Mehkri Yusuf, Rivas Lorena Figueredo, Jules Rebecca, Tuna Ibrahim S, Hoh Brian L, Shuhaiber Hans H
Department of Neurosurgery, University of Florida College of Medicine, Gainesville, USA.
Department of Neurology, University of Florida College of Medicine, Gainesville, USA.
Cureus. 2021 Oct 29;13(10):e19121. doi: 10.7759/cureus.19121. eCollection 2021 Oct.
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the terminal portions of the internal carotid arteries (ICAs) and the development of a network of abnormal collateral vessels. This case depicts a 25-year-old African American female patient with neurofibromatosis type 1 (NF-1), whose initial hospital presentation occurred in a hypertensive emergency setting. Surveillance studies with magnetic resonance imaging (MRI) revealed multiple asymptomatic right cortical strokes. Genetic testing evidenced a novel, unique pathogenic variant on the NF-1 geneThe patient underwent combined bypass surgery first and then was placed on aspirin and a blood pressure control regimen. Our case illustrates the need for clinicians to include moyamoya disease in the list of differential diagnoses when encountering a young patient, without major risk factors, presenting with ischemic stroke. It should be considered even with no known history of previously diagnosed MMD or NF-1, as these pathologies may have yet to be evaluated in subclinical cases.
烟雾病(MMD)是一种罕见的脑血管疾病,其特征是颈内动脉(ICA)末端逐渐狭窄,并形成异常侧支血管网络。本病例描述了一名患有1型神经纤维瘤病(NF-1)的25岁非裔美国女性患者,她最初在高血压急症情况下入院。磁共振成像(MRI)监测研究发现多处无症状的右侧皮质中风。基因检测证实NF-1基因存在一种新的、独特的致病变异。该患者首先接受了联合搭桥手术,然后服用阿司匹林并采用血压控制方案。我们的病例表明,临床医生在遇到无主要危险因素的年轻缺血性中风患者时,需要将烟雾病纳入鉴别诊断清单。即使没有先前诊断为MMD或NF-1的已知病史,也应考虑到这一点,因为这些病症在亚临床病例中可能尚未得到评估。